NCT06902194 To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
| NCT ID | NCT06902194 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Desmond Tutu TB Centre |
| Condition | Respiratory Tract Infections (RTI) |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2024-10-23 |
| Primary Completion | 2025-11-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The goal of this observational study is to answer a few questions about respiratory tract infections in South African children: 1. How do children with COVID-19 and other respiratory (chest, throat, ear or nose) germs show symptoms? What signs should be looked for, and which children are more likely to get seriously ill? Are there any new germs that haven't been discovered yet? Can immune cells in saliva predict which children will get more severe disease? 2. The body's immune response (soldier- cells) in blood and saliva (spit) will be studied. 3. What is the short-term effect of COVID-19 and other respiratory viruses/ germs on the breathing (lung function) of children? 4. What is the impact of respiratory germs on the quality of life in children and their families? The investigators aim to recruit a minimum of 250 children with respiratory pathogens.
Eligibility Criteria
Inclusion Criteria: \- Children aged 0-13 years with acute respiratory tract infections presenting to Tygerberg Hospital (TBH) in Cape Town, South Africa, for routine care Exclusion Criteria: * Admitted for \< 72 hours